Literature DB >> 16245361

Altered primary CD8+ T cell response to a modified virus Ankara(MVA)-vectored vaccine in the absence of CD4+ T cell help.

Marie J Estcourt1, Andrew J McMichael, Tomás Hanke.   

Abstract

T cell receptor-transgenic F5 mice were used to assess primary CD8+ T cell responses to a modified virus Ankara (MVA)-vectored vaccine in the absence of CD4+ T cell help. Naive, CD8-enriched, CFSE-labelled F5 cells were transferred into normal or CD4+ cell-depleted mice and the mice were vaccinated with MVA.HIVA-NP. At different time points during the primary response, F5 cells were re-isolated and analysed on divisional basis for a number of parameters. We demonstrated that the primary CD8+ T cell response in the absence of CD4+ T cell help differed from that in normal CD4+ cell-undepleted mice. While in the absence of CD4+ T cell help, the initial migratory progress from the local response to a systemic one was not grossly affected, the proportion of dying F5 cells during the expansion phase was markedly increased and resulted in an overall smaller expansion and significantly decreased frequency of CD8+ T cell memory after contraction. T cells primed without help displayed accelerated proliferation and activation, while expression of interferon-gamma remained similar. These phenomena were observed in the lymph nodes draining the MVA.HIVA-NP immunization site and were similar, but delayed by 2-3 days in spleen and non-draining lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16245361     DOI: 10.1002/eji.200526284

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

1.  Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect.

Authors:  Samantha Brandler; Alice Lepelley; Marion Desdouits; Florence Guivel-Benhassine; Pierre-Emmanuel Ceccaldi; Yves Lévy; Olivier Schwartz; Arnaud Moris
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

2.  Generating functional CD8+ T cell memory response under transient CD4+ T cell deficiency: implications for vaccination of immunocompromised individuals.

Authors:  Corey Smith; Michelle Martinez; Leanne Cooper; Michael Rist; Jie Zhong; Rajiv Khanna
Journal:  Eur J Immunol       Date:  2008-07       Impact factor: 5.532

3.  Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1.

Authors:  Louise A Johnson; Suneale Banerji; William Lawrance; Uzi Gileadi; Gennaro Prota; Kayla A Holder; Yaowaluck M Roshorm; Tomáš Hanke; Vincenzo Cerundolo; Nicholas W Gale; David G Jackson
Journal:  Nat Immunol       Date:  2017-05-15       Impact factor: 25.606

4.  Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45.

Authors:  Michael Pritsch; Najib Ben-Khaled; Michael Chaloupka; Sebastian Kobold; Nicole Berens-Riha; Annabell Peter; Gabriele Liegl; Sören Schubert; Michael Hoelscher; Thomas Löscher; Andreas Wieser
Journal:  J Immunol Res       Date:  2016-04-27       Impact factor: 4.818

5.  CD70 encoded by modified vaccinia virus Ankara enhances CD8 T-cell-dependent protective immunity in MHC class II-deficient mice.

Authors:  Barbara Bathke; Juliane Pätzold; Ronny Kassub; Raphael Giessel; Kerstin Lämmermann; Maria Hinterberger; Kay Brinkmann; Paul Chaplin; Mark Suter; Hubertus Hochrein; Henning Lauterbach
Journal:  Immunology       Date:  2018-01-26       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.